The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. There has been significant progress in understanding the risk factors and epidemiology of HCC during the last few decades, resulting in efficient preventative, diagnostic and treatment strategies. Type 2...

Full description

Bibliographic Details
Main Authors: Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
metformin
hepatocellular carcinoma
diabetes mellitus
antineoplastic
survival
sorafenib
Online Access:https://www.mdpi.com/2072-6694/15/12/3161

Internet

https://www.mdpi.com/2072-6694/15/12/3161

Similar Items